共 50 条
- [27] FDA Approvals of Oncology Drugs for Tissue-Agnostic Indications Targeted Oncology, 2023, 18 : 777 - 792
- [29] FDA Approves Two New Indications and Dosage Form for Pembrolizumab ONCOLOGY-NEW YORK, 2019, 33 (05): : 186 - 186
- [30] Drug eluting stents are safe for licensed indications, says FDA BRITISH MEDICAL JOURNAL, 2006, 333 (7581): : 1235 - 1235